Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-29

FDA Approved: CLOFARABINE — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for clofarabine from Dr. Reddy's Laboratories Inc, marking an approved update to the generic drug's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clofarabine (clofarabine)

Snippet

SUPPL AP for CLOFARABINE (CLOFARABINE)